跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DX HK NAD+III - TGA Drug Approval Details
Approvals
/
TGA
/
DX HK NAD+III
Approved
STANDARD
DX HK NAD+III
Australia Biotechnology Group Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4cf5723cd36375d0
Company
Australia Biotechnology Group Pty Ltd
Type
Standard
Approval Details
Approval Id
4cf5723cd36375d0
Product Name
DX HK NAD+III
Artg Id
349164
Artg Name
DX HK NAD+III
Sponsor
Australia Biotechnology Group Pty Ltd
Company Detail Path
/organization/australia-biotechnology-group-pty-ltd
Artg Date
2020-11-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4cf5723cd36375d0
Type
Standard
Back to TGA Approvals